Cargando…
Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States
Hepatotoxicity due to drugs, herbal or dietary supplements remains largely a clinical diagnosis based on meticulous history taking and exclusion of other causes of liver injury. In 2004, the U.S. Drug-Induced Liver Injury Network (DILIN) was created under the auspices of the U.S. National Institute...
Autor principal: | Hayashi, Paul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783935/ https://www.ncbi.nlm.nih.gov/pubmed/26861284 http://dx.doi.org/10.3390/ijms17020201 |
Ejemplares similares
-
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021) -
Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method
por: Ye, Ling, et al.
Publicado: (2021) -
Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
por: Teschke, Rolf, et al.
Publicado: (2017) -
Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020) -
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
por: Danan, Gaby, et al.
Publicado: (2019)